Compound information
- Natural Products
- ZC1539
- Molecular Formula
- C10H8N2O4
- Molecular Weight
- 220.048406736 g/mol
- Structure
-
- IUPAC Name
- 1-[2-(2,5-dioxopyrrol-1-yl)ethyl]pyrrole-2,5-dione
- InChI
- InChI=1S/C10H8N2O4/c13-7-1-2-8(14)11(7)5-6-12-9(15)3-4-10(12)16/h1-4H,5-6H2
- InChI Key
- PUKLCKVOVCZYKF-UHFFFAOYSA-N
- SMILES
- O=C1C=CC(=O)N1CCN1C(=O)C=CC1=O
- Source
- ZINC000004203455
Warheads
- Acrylamide
-
- Acrylamide
-
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 16 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 74.76 Å2 | LogP | 0.316 |
LogS | -2.43 | LogD | -0.324 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.175 | Pgp substrate | 0.124 |
HIA | 0.87 | F20 % | 0.974 |
F30 % | 0.145 | Caco-2 | -5.13 |
MDCK | -4.517 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.999 | PPB | 76.751 |
VD | 0.983 | Fu | 0.763 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.339 | CYP1A2 substrate | 0.474 |
CYP2A6 substrate | 0.26 | CYP2B6 substrate | 0.474 |
CYP2C19 inhibitor | 0.217 | CYP2C19 substrate | 0.481 |
CYP2C8 substrate | 0.424 | CYP2C9 inhibitor | 0.221 |
CYP2C9 substrate | 0.049 | CYP2D6 inhibitor | 0.064 |
CYP2D6 substrate | 0.165 | CYP2E1 substrate | 0.36 |
CYP3A4 inhibitor | 0.052 | CYP3A4 substrate | 0.07 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.832 | CL | 3.329 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.051 | Hepatotoxicity | 0.434 |
Mutagenicity | 0.064 | Rat Oral Acute Toxicity | 0.582 |
FDAMDD | 0.665 | Skin Sensitization | 0.992 |
Carcinogenicity | 0.887 | Eye Corrosion | 0.009 |
Eye Irritation | 0.969 | Respiratory Toxicity | 0.118 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.777 | IGC50 | 3.955 |
LC50FM | -2.31 | LC50DM | 2.382 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.159 | NR-AR-LBD | 0.726 |
NR-AhR | 0.01 | NR-Aromatase | 0.36 |
NR-ER | 0.212 | NR-ER-LBD | 0.538 |
NR-PPAR-gamma | 0.911 | SR-ARE | 0.923 |
SR-ATAD5 | 0.71 | SR-HSE | 0.966 |
SR-MMP | 0.637 | SR-p53 | 0.951 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.